""Linagliptin 5mg""

Linagliptin
LINALIGLIP is a medication used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. LINALIGLIP helps lower blood sugar levels by inhibiting the enzyme DPP-4, which is responsible for breaking down incretin hormones. Incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play a vital role in regulating blood glucose levels.
Here are some key points about LINALIGLIP:
Mechanism of Action: LINALIGLIP works by blocking the DPP-4 enzyme, which allows incretin hormones to remain active for a more extended period. This action stimulates the release of insulin from the pancreas in response to elevated blood glucose levels. It also reduces the production of glucagon, a hormone that increases blood sugar levels, leading to better blood sugar control.
Indications: LINALIGLIP is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not used for the treatment of type 1 diabetes or diabetic ketoacidosis.
Dosage and Administration: LINALIGLIP is available in tablet form and is usually taken orally once daily. The recommended dose may vary based on individual patient factors and other medications they may be taking. It is important to follow the prescribed dosage and consult a healthcare professional for proper administration.
Precautions and Side Effects: While generally well-tolerated, 
LINALIGLIP may cause side effects. Common side effects include upper respiratory tract infections, stuffy or runny nose, sore throat, and headache. Serious side effects, though rare, may include pancreatitis (inflammation of the pancreas) and allergic reactions. Patients should seek immediate medical attention if they experience severe abdominal pain, persistent nausea, or signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness, or trouble breathing).
Drug Interactions: LINALIGLIP may interact with other medications, potentially affecting their efficacy or safety. It is essential to inform your healthcare provider about all the medications, including prescription, over-the-counter, and herbal supplements, that you are taking to avoid potential interactions.
Contraindications: LINALIGLIP is generally not recommended for use in patients with a history of hypersensitivity to the drug or its components.
Pregnancy and Breastfeeding: The safety of LINALIGLIP during pregnancy and breastfeeding has not been adequately studied. If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to discuss the potential risks and benefits of using linagliptin with your healthcare provider.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/linaliglip-5-134269